Use of antiepileptic drugs in hepatic and renal disease.
Asconapé JJ.
Handb Clin Neurol. 2014;119:417-32. doi: 10.1016/B978-0-7020-4086-3.00027-8.
Liver.
Piñeiro-Carrero VM, Piñeiro EO.
Pediatrics. 2004 Apr;113(4 Suppl):1097-106.
Halothane hepatitis revisited.
Brown BR Jr.
N Engl J Med. 1985 Nov 21;313(21):1347-8. doi: 10.1056/NEJM198511213132108.
Nitrofurantoin.
D'Arcy PF.
Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):540-7. doi: 10.1177/106002808501900706.
Free phenytoin toxicity.
Imam SH, Landry K, Kaul V, Gambhir H, John D, Kloss B.
Am J Emerg Med. 2014 Oct;32(10):1301.e3-4. doi: 10.1016/j.ajem.2014.03.036. Epub 2014 Apr 1.
Needles in haystacks.
Reuben A.
Am J Gastroenterol. 2007 Nov;102(11):2444-6. doi: 10.1111/j.1572-0241.2007.01450.x.
Phenytoin-induced dyskinesia: a case report.
Shah KC, Patel NS, Vasani P, Khadela A, Chavda VP, Vora L.
J Med Case Rep. 2023 Jul 21;17(1):313. doi: 10.1186/s13256-023-04033-6.
Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
Kamitaki BK, Minacapelli CD, Zhang P, Wachuku C, Gupta K, Catalano C, Rustgi V.
Epilepsy Behav. 2021 Apr;117:107832. doi: 10.1016/j.yebeh.2021.107832. Epub 2021 Feb 21.
Phenytoin and damage to the cerebellum - a systematic review of published cases.
Ferner R, Day R, Bradberry SM.
Expert Opin Drug Saf. 2022 Jul;21(7):957-977. doi: 10.1080/14740338.2022.2058487. Epub 2022 Apr 20.
Phenytoin-induced chronic hepatitis.
Roy AK, Mahoney HC, Levine RA.
Dig Dis Sci. 1993 Apr;38(4):740-3. doi: 10.1007/BF01316808.
